AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Feb 28, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santibanez, T. A.
Right arrow Articles by Barker, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santibanez, T. A.
Right arrow Articles by Barker, L. E.
Related Collections
Right arrow Immunization/Vaccines
Differential Effects of the DTaP and MMR Vaccine Shortages on Timeliness of Childhood Vaccination Coverage

Tammy A. Santibanez, PhD, Jeanne M. Santoli, MD, MPH and Lawrence E. Barker, PhD

The authors are with the Centers for Disease Control and Prevention, Atlanta, Ga.


Figure 1
View larger version (19K):

[in a new window]
 
FIGURE 1— Vaccination coverage with the fourth dose of diphtheria and tetanus toxoids and pertussis vaccine (DTaP4) by eligibility for vaccination during the shortage and among children vaccinated only at public clinics (a,b), children vaccinated only at private practices (c,d), and children vaccinated at other or a mixture of practice types (e,f).

Note. The graphs in the left column depict age versus the percentage (cumulative) of children receiving DTaP4 by that age, comparing children eligible for vaccination during the shortage (solid lines) versus those not eligible dashed lines). The graphs in the right column represent the differences (solid lines) and their 95% confidence intervals (dashed lines). Statistically significant differences in vaccination coverage between children eligible for DTaP4 vaccination during the shortage and children not eligible for DTaP4 vaccination during the shortage have confidence intervals that do not include 0 (b).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Public Health Association